Literature DB >> 1943450

Physiological and pharmacological properties of adenosine: therapeutic implications.

J L Daval1, A Nehlig, F Nicolas.   

Abstract

Adenosine is a nucleoside which has been shown to participate in the regulation of physiological activity in a variety of mammalian tissues, and has been recognized as a homeostatic neuromodulator. It exerts its actions via membrane-bound receptors which have been characterized using biochemical, electrophysiological and radioligand binding techniques. Adenosine has been implicated in the pharmacological actions of several classes of drugs. A number of studies strongly suggest that the nucleoside may regulate cellular activity in many pathological disorders and, in that respect, adenosine derivatives appear as promising candidates for the development of new therapeutic compounds, such as anticonvulsant, anti-ischemic, analgesic and neuroprotective agents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1943450     DOI: 10.1016/0024-3205(91)90043-b

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  21 in total

Review 1.  5'-Nucleotidase: molecular structure and functional aspects.

Authors:  H Zimmermann
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

2.  Interaction of opioids with antidepressant-induced antinociception.

Authors:  F Sierralta; G Pinardi; M Mendez; H F Miranda
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

3.  Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus.

Authors:  T V Dunwiddie; L Diao; H O Kim; J L Jiang; K A Jacobson
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

4.  Neuroprotective effect of paeoniflorin on cerebral ischemic rat by activating adenosine A1 receptor in a manner different from its classical agonists.

Authors:  Da-Zhi Liu; Ke-Qiang Xie; Xin-Quan Ji; Yang Ye; Cheng-Liang Jiang; Xing-Zu Zhu
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

5.  The lipid peroxidation product 4-hydroxynonenal potently and selectively inhibits synaptic plasma membrane ecto-ATPase activity, a putative regulator of synaptic ATP and adenosine.

Authors:  T D Foley
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

6.  Striatum adenosine A2 receptors are modified during seizure: effect of cyclopentyladenosine administration.

Authors:  L Giraldez; F Zanetti; E Girardi
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

7.  CNS adenosine A1 receptors are altered after the administration of convulsant 3-mercaptopropionic acid and cyclopentyladenosine: an autoradiographic study.

Authors:  L Giraldez; F Zanetti; M C Antonelli; G Rodríguez de Lores Arnaiz; E Girardi
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

8.  Acute effect of low dose theophylline on the circulatory disturbances of cirrhosis.

Authors:  E H Forrest; I A Bouchier; P C Hayes
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

9.  Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor.

Authors:  Hua-Qing Liu; Wei-Yu Zhang; Xue-Ting Luo; Yang Ye; Xing-Zu Zhu
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

10.  AMP N(1)-oxide, a unique compound of royal jelly, induces neurite outgrowth from PC12 cells via signaling by protein kinase A independent of that by mitogen-activated protein kinase.

Authors:  Noriko Hattori; Hiroshi Nomoto; Hidefumi Fukumitsu; Satoshi Mishima; Shoei Furukawa
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-29       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.